Otsuka Pharmaceutical

Two businessmen pushing giant puzzle pieces together as the sun sets behind them

Otsuka buys Transcend in $1.2B deal, nabbing MDMA analog

Otsuka Pharmaceutical has acquired Transcend Therapeutics for $700 million upfront in a deal that could also deliver up to $525 million in milestones.

Will Maddox Mar 27, 2026 11:00am

Scary red cartoon eyes in dark background

Otsuka pens $420M deal for Asia rights to 4DMT gene therapy

Oct 31, 2025 5:09am

Otsuka inks $613M deal for Swedish biotech's IL1RAP antibodies

Jul 16, 2025 1:37pm

UPDATED: Taiho’s discontinues ph. 3 trial after DMD miss

Jul 8, 2025 10:17am

Colorful sailing boats at Fishermans Wharf of San Francisco Bay

Otsuka's $670M pact to point Harbour's TCE to autoimmune disease

Jun 23, 2025 6:29am

Otsuka's kidney disease drug halves UPCR levels in ph. 3 study

Jun 6, 2025 6:26am